Benzinga | Jun 14, 2021 07:00AM EDT

GSK And Iteos Announce Collaboration For Eos-448; Eos-448 Is Currently In Phase I For Advanced Solid Tumours With A Randomised Pd-1 Combination Study Planned For 2022

- Reuters